The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
Blog |
Improving diversity in clinical trials is both an equity issue and a scientific necessity
Blog |
Building momentum through the VPAG review
News |
ABPI response to publication of England's Rare Diseases Action Plan 2026
News |
New report underlines the health and economic opportunity from boosting industry clinical trials
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
Joint Innovate UK - ABPI AI in Medicines Discovery Symposium
NICE/DTSU/ABPI Masterclass: What makes a good submission to NICE?
ABPI Annual Conference 2026
ABPI’s flagship annual conference will be taking place in Central London on 23 April 2026.
SAVE THE DATE - ABPI Industry Summit 2026
This event, for ABPI members and invited guests, will assess the way industry builds familiarity and trust, and will ask if we need to challenge ourselves to work differently to achieve radical change for patients.
Economic statistics
£17.6bn
direct Gross Value Added (GVA) [1]
£9.3bn
investment in UK R&D in 2024 [2]
£1 in every £6
invested by the private sector in R&D is invested by the pharmaceutical industry [3]